With 20+ years industry experience, Aman Khera discusses the importance of recruiting an inclusive patient population.

In this article Aman Khera and Tom Zietlow from Kineticos discuss how COVID-19 has changed perceptions of clinical research and what that means for the industry moving forward.

Use and abuse of opioid products has increased alarmingly over the last 20 years. Read our article discussing the latest FDA guidance on the development of new drug treatments for opioid use disorder.

In this Applied Clinical Trials blog, Aman Khera shares her perspective on CTTI’s vision for the future of clinical trials, and how COVID-19 has impacted the industry.

With significant variations in the effects of COVID-19 among various ethnic, racial, and minority groups, how do we ensure vaccine trials are accurately establishing efficacy and safety across all patient populations? Beyond the ethical considerations, diversity is a medical and scientific imperative. This peer-reviewed article identifies tools and considerations for achieving representative diversity in enrolment for COVID-19 vaccine registration trials.

Read this article about findings from the most recent Biopharma Confidence Index that show that the pandemic has substantially influenced biopharma executives’ expectations in key areas like artificial intelligence/machine learning and real-world evidence.